ORAOV1 Antikörper (Internal Region)
-
- Target Alle ORAOV1 Produkte
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
-
Bindungsspezifität
- AA 50-130, Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ORAOV1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal to ORAOV1.
- Spezifität
- ORAOV1 Polyclonal Antibody detects endogenous levels of ORAOV1 protein.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human ORAOV1
- Isotyp
- IgG
-
-
- Applikationshinweise
-
WB 1:500-1:2000
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:10000 - Kommentare
-
Widely expressed. Highly expressed in placenta, kidney and skeletal muscle.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
- Andere Bezeichnung
- ORAOV1 (ORAOV1 Produkte)
- Synonyme
- TAOS1 antikoerper, 2210010N10Rik antikoerper, oral cancer overexpressed 1 antikoerper, ORAOV1 antikoerper, Oraov1 antikoerper
- Molekulargewicht
- 15 kDa
- Gen-ID
- 220064
- UniProt
- Q8WV07
-